Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Shire
Company Monitoring Page for Shire
latest headlines for company on cafepharma
Drug stocks slip; Shire climbs on earnings report
Marketwatch
Fri, 02/19/10 - 10:53 am
Tags:
drug stocks
,
Shire
Shire Profit Rises on Higher Vyvanse Sales
Bloomberg
Fri, 02/19/10 - 09:14 am
Tags:
Shire
,
earnings
,
Vyvanase
Genzyme rivals unleash barrage of promising Gaucher data
Fierce Biotech
Fri, 02/12/10 - 09:04 am
Tags:
Genzyme
,
Gaucher disease
,
Shire
,
Protalix BioTherapeutics
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 10:58 am
Tags:
FDA
,
Cadence Pharmaceuticals
,
Acorda Therapeutics
,
Auxilium
,
Gilead Sciences
,
Shire
,
Amylin
,
Cell Therapeutics
,
Dendreon
,
InterMune
,
Amgen
,
Human Genome
,
NicOx
,
Vivus
,
Arena Pharmaceuticals
,
Orexigen
Broker comments lift pharma stocks
FT.com
Mon, 02/8/10 - 10:16 am
Tags:
drug stocks
,
Teva Pharmaceuticals
,
GSK
,
Pfizer
,
Shire
,
UCB Pharmaceuticals
,
Merck KGaA
Biotech Events to Watch in 2010: FDA Approvals, Expected Deals and Surprises!
BNET Pharma
Mon, 02/1/10 - 10:11 am
Tags:
biotech
,
FDA
,
Cadence Pharmaceuticals
,
Acetavance
,
Gilead Sciences
,
Cayston
,
velaglucerase
,
Shire
,
Exenatide LAR
,
Amylin
,
Cephalon
,
NUVIGIL
,
Cell Therapeutics
,
pixantrone
,
Dendreon
,
Provenge
Genzyme: Shire Chomping at the Bit
Seeking Alpha
Tue, 01/19/10 - 09:36 am
Tags:
Shire
,
Genzyme
,
Amicus Therapeutics
Facing Stunted Growth in ADHD Market, Shire Clicks on Twitter
BNET Pharma
Sun, 01/3/10 - 11:42 am
Tags:
Shire
,
ADHD
,
social media
,
twitter
,
Vyvanase
Shire Seeks FDA Approval
Yahoo/Zacks.com
Mon, 12/28/09 - 10:18 am
Tags:
Shire
,
FDA
,
Fabry's disease
,
Replagal
,
Genzyme
FDA to issue decision on Shire's Gaucher drug
Marketwatch
Tue, 12/22/09 - 04:11 pm
Tags:
FDA
,
Shire
,
Gaucher disease
Biotech Calendar: Upcoming FDA Dates
TheStreet.com
Tue, 12/15/09 - 08:54 am
Tags:
FDA
,
Dendreon
,
Arena Pharmaceuticals
,
Chelsea Therapeutics
,
Cephalon
,
Biodel
,
Auxilium
,
Novartis
,
Novo Nordisk
,
Shire
,
Vivus
,
MannKind
,
Acorda Therapeutics
Bayer Advances on Alzheimer's Plan
Yahoo/Zacks.com
Fri, 12/4/09 - 08:57 am
Tags:
Alzheimer's disease
,
Bayer
,
Novartis
,
Pfizer
,
Shire
,
florbetaben
Shire, Teva settle Adderall contract lawsuit
Yahoo/AP
Wed, 12/2/09 - 09:34 am
Tags:
Shire
,
Teva Pharmaceuticals
,
Adderall
,
generics
Shire’s Replagal Improves Quality of Life for Fabry’s Patients
Bloomberg
Wed, 12/2/09 - 09:25 am
Tags:
Fabry's disease
,
Shire
,
Replagal
Drug stocks sluggish; Shire gains in early action
Marketwatch
Tue, 11/24/09 - 09:58 am
Tags:
drug stocks
,
Shire
Shire applies for Euro approval of Gaucher drug
Marketwatch
Tue, 11/24/09 - 09:56 am
Tags:
Shire
,
Europe
,
Gaucher disease
Shire gets boost as FDA backs Vyvanse exclusivity
Reuters
Mon, 10/26/09 - 11:55 am
Tags:
Shire
,
FDA
,
Vyvanase
,
ADHD
Shire and Sandoz settle Adderall XR patent suits
Yahoo/AP
Tue, 10/13/09 - 06:07 pm
Tags:
Shire
,
Sandoz
,
Adderall XR
,
generics
Impax shipping generic of ADHD drug Adderall XR
Yahoo/AP
Thu, 10/1/09 - 04:57 pm
Tags:
Impax
,
ADHD
,
generics
,
Shire
,
Adderall
Shire Set for $50 Million Windfall on Demand for Gaucher Drug
Bloomberg
Fri, 09/11/09 - 08:21 am
Tags:
Shire
,
Genzyme
,
Gaucher disease
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.